Technetium-99m sestamibi scintigraphy in monitoring patients with multiplemyeloma

Authors
Pinto, AM Califano, C Di Gennaro, F De Renzo, A Catalano, L Pace, L
Citation
Am. Pinto et al., Technetium-99m sestamibi scintigraphy in monitoring patients with multiplemyeloma, HAEMATOLOG, 85(9), 2000, pp. 1000-1001
Citations number
10
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
HAEMATOLOGICA
ISSN journal
03906078 → ACNP
Volume
85
Issue
9
Year of publication
2000
Pages
1000 - 1001
Database
ISI
SICI code
0390-6078(200009)85:9<1000:TSSIMP>2.0.ZU;2-6
Abstract
Technetium-99m-Sestamibi (Tc-99m-sestamibi) scintigraphy has been shown to be capable of differentiating patients with multiple myeloma (MM) in remiss ion from those with active disease.(1-10) We studied 5 patients with MM (2 females and 3 males, age 53+/-17 years) before and after treatment. Tc-99m- sestamibi scintigraphic results were concordant with clinical status.